| 51.13 Data as of Jun 18 | +1.16 / +2.32%Today’s Change | 36.73 Today|||52-Week Range 56.68 | +21.59% Year-to-Date |
The 13 analysts offering 12-month price forecasts for Cubist Pharmaceuticals Inc have a median target of 59.00, with a high estimate of 69.00 and a low estimate of 44.00. The median estimate represents a +15.39% increase from the last price of 51.13.

The current consensus among 19 polled investment analysts is to Hold stock in Cubist Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




